ofloxacin has been researched along with Spinal Cord Injuries in 2 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Spinal Cord Injuries: Penetrating and non-penetrating injuries to the spinal cord resulting from traumatic external forces (e.g., WOUNDS, GUNSHOT; WHIPLASH INJURIES; etc.).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty two paraplegic and quadriplegic hospitalized spinal cord injured patients with urinary tract infections (UTI) were included in a double blind, randomized treatment study comparing 7 days ofloxacin (300 mg bd) with trimethoprim-sulphamethoxazole (TMPSMX; 160-800 mg bd) or an alternative, chosen because of resistance to TMPSMX." | 9.09 | Ofloxacin for the treatment of urinary tract infections and biofilms in spinal cord injury. ( Delaney, G; Hayes, K; Hsieh, J; Nicosia, S; Potter, P; Reid, G, 2000) |
| "Forty two paraplegic and quadriplegic hospitalized spinal cord injured patients with urinary tract infections (UTI) were included in a double blind, randomized treatment study comparing 7 days ofloxacin (300 mg bd) with trimethoprim-sulphamethoxazole (TMPSMX; 160-800 mg bd) or an alternative, chosen because of resistance to TMPSMX." | 5.09 | Ofloxacin for the treatment of urinary tract infections and biofilms in spinal cord injury. ( Delaney, G; Hayes, K; Hsieh, J; Nicosia, S; Potter, P; Reid, G, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brousse, C | 1 |
| Montigny, JP | 1 |
| Marroun, I | 1 |
| Garreau de Loubresse, C | 1 |
| Kahn, JE | 1 |
| Reid, G | 1 |
| Potter, P | 1 |
| Delaney, G | 1 |
| Hsieh, J | 1 |
| Nicosia, S | 1 |
| Hayes, K | 1 |
1 trial available for ofloxacin and Spinal Cord Injuries
| Article | Year |
|---|---|
Ofloxacin for the treatment of urinary tract infections and biofilms in spinal cord injury.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents, Urinary; Biofilms; Double-Blin | 2000 |
1 other study available for ofloxacin and Spinal Cord Injuries
| Article | Year |
|---|---|
[Charcot's disease of the lumbosacral joint in spinal cord injury: a case report].
Topics: Accidents, Traffic; Adult; Arthropathy, Neurogenic; Bacteremia; Diagnostic Errors; Discitis; Epidura | 2008 |